Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Greece Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20033
20041
20052
20061
20073
20087
20095
20101
20111
20122
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated10
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hellenic Oncology Research Group6
University Hospital of Crete5
Hellenic Cooperative Oncology Group4
Hoffmann-La Roche3
GlaxoSmithKline2
Novartis Pharmaceuticals2
R-Pharm2
Bayer1
Boehringer Ingelheim1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms31
Brain Neoplasms3
Neoplasms3
Neoplasm Metastasis2
Prostatic Neoplasms2
Breast Neoplasms, Male1
Carcinoma, Non-Small-Cell Lung1
Cardiotoxicity1
Inflammatory Breast Neoplasms1
Lung Neoplasms1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.